B. Y. AKTAŞ Et Al. , "Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia," Current Oncology , vol.30, no.11, pp.9689-9700, 2023
AKTAŞ, B. Y. Et Al. 2023. Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia. Current Oncology , vol.30, no.11 , 9689-9700.
AKTAŞ, B. Y., ATA, E. B., ÇEŞMECİ, E., ÇAKIR, İ. Y., Coşkunpınar, M., TAHILLIOĞLU, Y., ... GÜNER, G.(2023). Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia. Current Oncology , vol.30, no.11, 9689-9700.
AKTAŞ, BURAK Et Al. "Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia," Current Oncology , vol.30, no.11, 9689-9700, 2023
AKTAŞ, BURAK Y. Et Al. "Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia." Current Oncology , vol.30, no.11, pp.9689-9700, 2023
AKTAŞ, B. Y. Et Al. (2023) . "Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia." Current Oncology , vol.30, no.11, pp.9689-9700.
@article{article, author={BURAK YASİN AKTAŞ Et Al. }, title={Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia}, journal={Current Oncology}, year=2023, pages={9689-9700} }